{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:17:36Z","timestamp":1773094656743,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ9229"],"award-info":[{"award-number":["2024JJ9229"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900070"],"award-info":[{"award-number":["81900070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04566-4","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:25:23Z","timestamp":1770326723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of DNA mismatch repair and microsatellite instability in molecular typing of endometrial carcinoma"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0137-4739","authenticated-orcid":false,"given":"Na-Mei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6953-986X","authenticated-orcid":false,"given":"Xiao-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"1","key":"4566_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent"},{"issue":"5","key":"4566_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, et al. Cancer statistics in China and united States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390. https:\/\/doi.org\/10.1097\/CM9.0000000000002108.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"4566_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3760\/cma.j.cn112151-20200712-00548","volume":"50","author":"H Xu","year":"2021","unstructured":"Xu H, Zhang J. Interpretation of updated pathological contents for cervical cancer in NCCN clinical practice guidelines, version 1, 2020. Zhonghua Bing Li Xue Za Zhi. 2021;50(1):9\u201313. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20200712-00548.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"5","key":"4566_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/his.14609","volume":"80","author":"WG McCluggage","year":"2022","unstructured":"McCluggage WG, Singh N, Gilks CB. Key changes to the world health organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology. 2022;80(5):762\u201378. https:\/\/doi.org\/10.1111\/his.14609.","journal-title":"Histopathology"},{"issue":"7447","key":"4566_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Cancer Genome Atlas Research Network, Kandoth C, Schultz N, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373. https:\/\/doi.org\/10.1038\/nature12113.","journal-title":"Nature"},{"key":"4566_CR6","doi-asserted-by":"publisher","first-page":"e000148","DOI":"10.1136\/gocm-2024-000148","volume":"5","author":"Y Dong","year":"2025","unstructured":"Dong Y, Zhao L, Kang N, et al. Chinese expert consensus on clinical application of molecular classification of endometrial cancer (2024). Gynecol Obstet Clin Med. 2025;5:e000148. https:\/\/doi.org\/10.1136\/gocm-2024-000148.","journal-title":"Gynecol Obstet Clin Med"},{"issue":"11","key":"4566_CR7","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.19401\/j.cnki.1007-3639.2021.11.012","volume":"31","author":"The Society of Gynecological Cancer of China Anti-Cancer Association, Chinese Society of Pathology of the Chinese Medical Association, National Pathology Quality Control Center","year":"2021","unstructured":"The Society of Gynecological Cancer of China Anti-Cancer Association, Chinese Society of Pathology of the Chinese Medical Association, National Pathology Quality Control Center. The Chinese expert consensus recommendations on molecular testing in endometrial cancer (2021 edition). China Oncol. 2021;31(11):1126\u201344. https:\/\/doi.org\/10.19401\/j.cnki.1007-3639.2021.11.012.","journal-title":"China Oncol"},{"issue":"1","key":"4566_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/his.13977","volume":"76","author":"IA Cree","year":"2020","unstructured":"Cree IA, White VA, Indave BI, Lokuhetty D. Revising the WHO classification: female genital tract tumours. Histopathology. 2020;76(1):151\u20136. https:\/\/doi.org\/10.1111\/his.13977.","journal-title":"Histopathology"},{"issue":"11","key":"4566_CR9","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3390\/cancers16112027","volume":"16","author":"IS Bostan","year":"2024","unstructured":"Bostan IS, Mihaila M, Roman V, et al. Landscape of endometrial cancer: molecular Mechanisms, Biomarkers, and target therapy. Cancers (Basel). 2024;16(11):2027. https:\/\/doi.org\/10.3390\/cancers16112027.","journal-title":"Cancers (Basel)"},{"issue":"13","key":"4566_CR10","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/1078-0432.CCR-18-4070","volume":"25","author":"L Marcus","year":"2019","unstructured":"Marcus L, Lemery SJ, Keegan P, Pazdur R. FDA approval summary: pembrolizumab for the treatment of microsatellite Instability-High solid tumors. Clin Cancer Res. 2019;25(13):3753\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-4070.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4566_CR11","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/cancers13061268","volume":"13","author":"J Siemanowski","year":"2021","unstructured":"Siemanowski J, Sch\u00f6mig-Markiefka B, Buhl T, et al. Managing difficulties of microsatellite instability testing in endometrial cancer-limitations and advantages of four different PCR-Based approaches. Cancers (Basel). 2021;13(6):1268. https:\/\/doi.org\/10.3390\/cancers13061268.","journal-title":"Cancers (Basel)"},{"key":"4566_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ygyno.2023.05.059","volume":"174","author":"E Rios-Doria","year":"2023","unstructured":"Rios-Doria E, Momeni-Boroujeni A, Friedman CF, et al. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma. Gynecol Oncol. 2023;174:262\u201372. https:\/\/doi.org\/10.1016\/j.ygyno.2023.05.059.","journal-title":"Gynecol Oncol"},{"issue":"23","key":"4566_CR13","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1002\/cam4.4832","volume":"11","author":"K Amemiya","year":"2022","unstructured":"Amemiya K, Hirotsu Y, Nagakubo Y, et al. Simple IHC reveals complex MMR alternations than PCR assays: validation by LCM and next-generation sequencing. Cancer Med. 2022;11(23):4479\u201390. https:\/\/doi.org\/10.1002\/cam4.4832.","journal-title":"Cancer Med"},{"issue":"3","key":"4566_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/cncr.35030","volume":"130","author":"CJ Riedinger","year":"2024","unstructured":"Riedinger CJ, Esnakula A, Haight PJ, et al. Characterization of mismatch-repair\/microsatellite instability-discordant endometrial cancers. Cancer. 2024;130(3):385\u201399. https:\/\/doi.org\/10.1002\/cncr.35030.","journal-title":"Cancer"},{"issue":"1","key":"4566_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ijc.33763","volume":"150","author":"S Zhao","year":"2022","unstructured":"Zhao S, Chen L, Zang Y, et al. Endometrial cancer in Lynch syndrome. Int J Cancer. 2022;150(1):7\u201317. https:\/\/doi.org\/10.1002\/ijc.33763.","journal-title":"Int J Cancer"},{"issue":"2","key":"4566_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","volume":"16","author":"WJ Koh","year":"2018","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine Neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(2):170\u201399. https:\/\/doi.org\/10.6004\/jnccn.2018.0006.","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"4566_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/s41379-020-0501-8","volume":"33","author":"A Pasanen","year":"2020","unstructured":"Pasanen A, Loukovaara M, B\u00fctzow R. Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma. Mod Pathol. 2020;33(7):1443\u201352. https:\/\/doi.org\/10.1038\/s41379-020-0501-8.","journal-title":"Mod Pathol"},{"issue":"16","key":"4566_CR18","doi-asserted-by":"publisher","first-page":"16707","DOI":"10.1002\/cam4.6293","volume":"12","author":"S Bartels","year":"2023","unstructured":"Bartels S, Grote I, Wagner M, et al. Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types. Cancer Med. 2023;12(16):16707\u201315. https:\/\/doi.org\/10.1002\/cam4.6293.","journal-title":"Cancer Med"},{"issue":"10","key":"4566_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3760\/cma.j.cn112141-20230711-00316","volume":"58","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang YX, Sun XJ, et al. Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma. Zhonghua Fu Chan Ke Za Zhi. 2023;58(10):755\u201365. https:\/\/doi.org\/10.3760\/cma.j.cn112141-20230711-00316.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"4566_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.humpath.2021.02.006","volume":"111","author":"J Huvila","year":"2021","unstructured":"Huvila J, Orte K, Vainio P, et al. Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and proactive molecular risk classifier for endometrial cancer classifier. Hum Pathol. 2021;111:98\u2013109. https:\/\/doi.org\/10.1016\/j.humpath.2021.02.006.","journal-title":"Hum Pathol"},{"issue":"10","key":"4566_CR21","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1002\/ijc.33115","volume":"147","author":"ME Salem","year":"2020","unstructured":"Salem ME, Bodor JN, Puccini A, et al. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors. Int J Cancer. 2020;147(10):2948\u201356. https:\/\/doi.org\/10.1002\/ijc.33115.","journal-title":"Int J Cancer"},{"key":"4566_CR22","doi-asserted-by":"publisher","first-page":"155152","DOI":"10.1016\/j.prp.2024.155152","volume":"254","author":"N Kang","year":"2024","unstructured":"Kang N, Zhang X, Wang Z, et al. Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population. Pathol Res Pract. 2024;254:155152. https:\/\/doi.org\/10.1016\/j.prp.2024.155152.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"4566_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/PGP.0000000000001096","volume":"44","author":"S Saharti","year":"2025","unstructured":"Saharti S, Altaf F. Molecular classification of endometrial carcinoma: insights from a teaching hospital. Int J Gynecol Pathol. 2025;44(4):336\u20139. https:\/\/doi.org\/10.1097\/PGP.0000000000001096.","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"4566_CR24","doi-asserted-by":"publisher","first-page":"100423","DOI":"10.1016\/j.modpat.2024.100423","volume":"37","author":"M Kaya","year":"2024","unstructured":"Kaya M, Post CCB, Tops CM, et al. Molecular and clinicopathologic characterization of mismatch Repair-Deficient endometrial carcinoma not related to MLH1 promoter hypermethylation. Mod Pathol. 2024;37(3):100423. https:\/\/doi.org\/10.1016\/j.modpat.2024.100423.","journal-title":"Mod Pathol"},{"issue":"19","key":"4566_CR25","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1158\/1078-0432.CCR-22-0713","volume":"28","author":"BL Manning-Geist","year":"2022","unstructured":"Manning-Geist BL, Liu YL, Devereaux KA, et al. Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles. Clin Cancer Res. 2022;28(19):4302\u201311. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-0713.","journal-title":"Clin Cancer Res"},{"key":"4566_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100843","author":"J Viana-Errasti","year":"2025","unstructured":"Viana-Errasti J, Mar\u00edn R, Garc\u00eda-Mulero S et al Comparative analysis of somatic and germline polymerase proofreading deficiencies in cancer: molecular and clinical implications. Mod Pathol. 2025. https:\/\/doi.org\/10.1016\/j.modpat.2025.100843.","journal-title":"Mod Pathol"},{"key":"4566_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2021.10.004","volume":"119","author":"MC Smithgall","year":"2022","unstructured":"Smithgall MC, Remotti H, Hsiao SJ, Mansukhani M, Liu-Jarin X, Fernandes H. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing. Hum Pathol. 2022;119:41\u201350. https:\/\/doi.org\/10.1016\/j.humpath.2021.10.004.","journal-title":"Hum Pathol"},{"issue":"11","key":"4566_CR28","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/genes14112060","volume":"14","author":"IW Carnevali","year":"2023","unstructured":"Carnevali IW, Cini G, Libera L, et al. MLH1 promoter methylation could be the second hit in Lynch syndrome carcinogenesis. Genes (Basel). 2023;14(11):2060. https:\/\/doi.org\/10.3390\/genes14112060.","journal-title":"Genes (Basel)"},{"issue":"1","key":"4566_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12885-018-4489-0","volume":"18","author":"T Yokoyama","year":"2018","unstructured":"Yokoyama T, Takehara K, Sugimoto N, et al. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review. BMC Cancer. 2018;18(1):576. https:\/\/doi.org\/10.1186\/s12885-018-4489-0.","journal-title":"BMC Cancer"},{"issue":"7","key":"4566_CR30","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.3390\/ijms23073794","volume":"23","author":"HJ Tung","year":"2022","unstructured":"Tung HJ, Wu RC, Lin CY, Lai CH. Rare subtype of endometrial cancer: undifferentiated\/dedifferentiated endometrial carcinoma, from genetic aspects to clinical practice. Int J Mol Sci. 2022;23(7):3794. https:\/\/doi.org\/10.3390\/ijms23073794.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4566_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pathol.2020.07.015","volume":"53","author":"K Zhang","year":"2021","unstructured":"Zhang K, Liu Y, Liu X, et al. Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas. Pathology. 2021;53(2):179\u201386. https:\/\/doi.org\/10.1016\/j.pathol.2020.07.015.","journal-title":"Pathology"},{"issue":"2","key":"4566_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cjp2.188","volume":"7","author":"B Tessier-Cloutier","year":"2021","unstructured":"Tessier-Cloutier B, Coatham M, Carey M, et al. SWI\/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma. J Pathol Clin Res. 2021;7(2):144\u201353. https:\/\/doi.org\/10.1002\/cjp2.188.","journal-title":"J Pathol Clin Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04566-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04566-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04566-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:13:40Z","timestamp":1773058420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04566-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4566"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04566-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of the Second Xiangya Hospital of Central South University (Ethics number: 2021010). Written informed consent was obtained from the patient for the publication of any potentially identifiable images or data included in this article. All the experiments in this study were conducted in compliance with the Declaration of Helsinki. The patients\/participants provided their written informed consent to participate in this study. Written informed consents were obtained from the patients for study participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study confirms that written informed consents (including consent to participate and consent to publish) has been obtained from all research participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"397"}}